Pulmonary toxicity from carmustine (BCNU
β
Weiss, Raymond B. ;Shah, Sheila ;Shane, Stanley R.
π
Article
π
1979
π
John Wiley and Sons
π
English
β 701 KB
A patient who had a pneumonectomy for lung carcinoma was treated with carmustine when brain metastases developed. His pulmonary function was mildly compromised prior to the pneumonectomy by many years of smoking. After six months of carmustine therapy [total dose: 2,250 mg (1,200 mg/m2)] he develope